Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients-Reference-Cited by-同舟云学术

Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients

Published:2020-09-17 Issue:1 Volume:15 Page:67-79
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Charo Lindsey M.¹^ORCID,Eskander Ramez N.¹,Okamura Ryosuke²,Patel Sandip P.²,Nikanjam Mina²^ORCID,Lanman Richard B.³,Piccioni David E.²,Kato Shumei²,McHale Michael T.¹,Kurzrock Razelle²

Affiliation:

1. Division of Gynecologic Oncology Department of Obstetrics, Gynecology, and Reproductive Sciences University of California San Diego Moores Cancer Center La Jolla CA USA

2. Center for Personalized Cancer Therapy and Division of Hematology and Oncology University of California San Diego Moores Cancer Center La Jolla CA USA

3. Guardant Health, Inc. Redwood City CA USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12791

Reference43 articles.

1. Cancer statistics, 2019

2. Hallmarks of Cancer: The Next Generation